Disc Medicine, Inc.
General ticker "IRON" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.3B (TTM average)
Disc Medicine, Inc. follows the US Stock Market performance with the rate: 46.7%.
Estimated limits based on current volatility of 2.1%: low 65.12$, high 67.97$
Factors to consider:
- Earnings expected soon, date: 2026-05-06 bmo
- Total employees count: 29 as of 2020
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [47.87$, 112.72$]
- 2026-12-31 to 2027-12-31 estimated range: [29.95$, 76.93$]
Financial Metrics affecting the IRON estimates:
- Negative: with PPE of -13.6 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -6.29 <= 0.07
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: negative Net income
- Negative: -0.15 < Industry inventory ratio change (median), % of 0
- Positive: Shareholder equity ratio, % of 91.69 > 64.25
Short-term IRON quotes
Long-term IRON plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $91.12MM | $129.72MM | $236.02MM |
| Operating Income | $-91.12MM | $-129.72MM | $-236.02MM |
| Non-Operating Income | $14.79MM | $20.72MM | $24.20MM |
| Interest Expense | $0.00MM | $0.57MM | $3.61MM |
| R&D Expense | $69.26MM | $96.67MM | $170.64MM |
| Income(Loss) | $-76.33MM | $-109.00MM | $-211.82MM |
| Taxes | $0.10MM | $0.35MM | $0.36MM |
| Profit(Loss)* | $-76.43MM | $-109.36MM | $-212.18MM |
| Stockholders Equity | $345.12MM | $443.59MM | $739.83MM |
| Assets | $368.00MM | $496.77MM | $806.88MM |
| Operating Cash Flow | $-73.46MM | $-93.93MM | $-180.39MM |
| Capital expenditure | $0.09MM | $0.51MM | $0.93MM |
| Investing Cash Flow | $-0.09MM | $-292.33MM | $-394.30MM |
| Financing Cash Flow | $239.38MM | $218.31MM | $473.41MM |
| Earnings Per Share** | $-3.42 | $-3.96 | $-6.01 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.